A phase II randomised study of chemo-anticoagulation (Gemcitabine-Dalteparin) vs Chemotherapy alone (Gemcitabine) for locally advanced and metastatic pancreatic adenocarcinoma

Pas encore traduit Pas encore traduit
Auteurs
Catégorie Primary study
Registry of TrialsISRCTN registry
Year 2003

This article is not included in any systematic review

This article is part of the following publication threads:
Loading references information
Cet article n'a pas de résumé
Epistemonikos ID: e17b7be0652fc5aa4f312ca3af1084be77549bfe
First added on: Jun 07, 2022